Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population
about
Social network sensors for early detection of contagious outbreaksRecipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virusThe Role of CD4 T Cell Memory in Generating Protective Immunity to Novel and Potentially Pandemic Strains of InfluenzaMeasuring Cellular Immunity to Influenza: Methods of Detection, Applications and ChallengesUniversal immunity to influenza must outwit immune evasionRevealing the role of CD4(+) T cells in viral immunityInduction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activityA contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virusCross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primatesStructural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza VirusCross-reactive CD8 + T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A virusesCrystal Structure of Swine Major Histocompatibility Complex Class I SLA-1*0401 and Identification of 2009 Pandemic Swine-Origin Influenza A H1N1 Virus Cytotoxic T Lymphocyte Epitope PeptidesPreemptive priming readily overcomes structure-based mechanisms of virus escapePreexisting CD8+ T-cell immunity to the H7N9 influenza A virus varies across ethnicitiesExhaled aerosol transmission of pandemic and seasonal H1N1 influenza viruses in the ferretOseltamivir Prophylaxis Reduces Inflammation and Facilitates Establishment of Cross-Strain Protective T Cell Memory to Influenza VirusesPandemic influenza A H1N1 2009 infection versus vaccination: a cohort study comparing immune responses in pregnancyImprovement of the trivalent inactivated flu vaccine using PapMV nanoparticlesIMMUNOCAT-a data management system for epitope mapping studiesEpitope specific T-cell responses against influenza A in a healthy population.Making vaccines "on demand": a potential solution for emerging pathogens and biodefense?Two years after pandemic influenza A/2009/H1N1: what have we learned?Theoretical basis to measure the impact of short-lasting control of an infectious disease on the epidemic peak.Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine developmentThe 1918 influenza pandemic: lessons for 2009 and the future.Universal H1N1 influenza vaccine development: identification of consensus class II hemagglutinin and neuraminidase epitopes derived from strains circulating between 1980 and 2011.Diet-induced obese mice exhibit altered heterologous immunity during a secondary 2009 pandemic H1N1 infectionImmunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic miceDifferential influenza H1N1-specific humoral and cellular response kinetics in kidney transplant patients.Immunization of rabbits with synthetic peptides derived from a highly conserved β-sheet epitope region underneath the receptor binding site of influenza A virusHumoral and cellular responses to a non-adjuvanted monovalent H1N1 pandemic influenza vaccine in hospital employeesExtreme evolutionary conservation of functionally important regions in H1N1 influenza proteome.Modified vaccinia virus Ankara expressing the hemagglutinin of pandemic (H1N1) 2009 virus induces cross-protective immunity against Eurasian 'avian-like' H1N1 swine viruses in mice.Determinants of individuals' risks to 2009 pandemic influenza virus infection at household level amongst Djibouti city residents--a CoPanFlu cross-sectional study.Cross-conservation of T-cell epitopes: now even more relevant to (H7N9) influenza vaccine design.Preexisting CD4+ T-cell immunity in human population to avian influenza H7N9 virus: whole proteome-wide immunoinformatics analyses.IL-15 adjuvanted multivalent vaccinia-based universal influenza vaccine requires CD4+ T cells for heterosubtypic protectionCharacterization of pandemic influenza immune memory signature after vaccination or infection.Expansion of genotypic diversity and establishment of 2009 H1N1 pandemic-origin internal genes in pigs in China.Rate of decline of antibody titers to pandemic influenza A (H1N1-2009) by hemagglutination inhibition and virus microneutralization assays in a cohort of seroconverting adults in Singapore
P2860
Q21091104-459A4D62-5E11-4642-A54D-950144DF4D20Q24600337-CBF550D9-95A8-4914-86E5-4C9BA29B8087Q26772701-1BDE1421-B070-44A0-A624-1E092C9007B2Q26783884-F527B3BB-0849-47B0-81A5-FB9E45507DE5Q26991896-5DA88B6F-2BA7-47CC-B361-52F5C8206D39Q26995409-9BA49780-221C-42D4-AFCF-B1542C209EEEQ27309214-58CE0E22-D7C3-4BB9-895E-7DE42FED4A40Q27316330-C1FDE172-B1C9-4579-BEA6-C1027687A3BDQ27348520-91A153E0-3A21-4D12-9CF2-8C85A84CFE56Q27660330-C82C163A-A19B-4524-9630-A8D6CB791EF0Q27663289-E9C2B98D-99CA-49ED-8D30-11AC79DABCF5Q27673392-39E7DDB1-BA23-4549-91D7-71733258A7BAQ27676834-0021520C-1BE4-43A7-AF40-1140573E73ACQ27681214-DA1DEDF8-AF0F-48D6-B533-0C7F273AC96DQ28382996-F537F12F-5869-442D-88EB-E0347D667FCEQ28548477-813F516B-2AB6-45CF-B63E-A9FA3A548F21Q28730978-7F00D270-574D-4900-86E3-8B1B9F6A6F26Q28743086-DE642D0C-5FD4-4291-8A35-E237CF6CD051Q28752157-86D5D7D3-E7A2-451E-9826-1AA564D9EF28Q30202358-8B2AA6E6-8646-459C-A9A8-632D4C036139Q30222126-7A7D9439-080C-44D1-AFF6-A2BEC6B70CA9Q30224656-7B364FBA-4EAD-4632-BCFD-94F7AA0E3EEAQ30226759-4ED479B1-F3BD-4389-8E89-C1EE80B3E6E8Q30226873-2D54322A-DDED-4434-BC98-1C36C212C8C8Q30227352-D603FA9E-86F1-42CB-8D2B-5211B5B298ACQ30352021-A9F91210-7E3B-4CB7-B0FE-5704F1977DA7Q30352501-64BE605F-2F16-4E7F-AA1D-00F75FB63C14Q30353698-4CDB43E9-B742-4A09-8920-671D79114A19Q30353821-8B304BA6-D32B-4649-8CD8-F0A3357FE436Q30355629-7167B15B-D7B7-432C-99C9-DB880C3D5A7AQ30355654-90B08A8D-8F6C-461E-A120-1E5CC3B06C92Q30356104-BB7E359F-244C-4DFD-BEAA-ACE6F8AE347FQ30357331-FD65168D-3448-456F-A7CA-3FB79A288469Q30358376-FF12A159-7CB7-4B87-BA8E-A2CFE957ADEEQ30358954-CD98CA9B-EF24-467B-8E07-690D36E2811CQ30359962-B7F1B48D-125C-4D78-9A1E-E41B25A36C09Q30361079-7EA2E911-0D79-4D35-A752-0AA37FD9EE2CQ30363416-7A4D92BA-9905-4102-9E2D-09E807F35643Q30364522-EBE23525-CD74-4713-A03A-A679FE4A309FQ30365168-816D5E90-97FE-4EE7-89ED-8077F721B767
P2860
Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Pre-existing immunity against ...... n the general human population
@ast
Pre-existing immunity against ...... n the general human population
@en
Pre-existing immunity against ...... n the general human population
@nl
type
label
Pre-existing immunity against ...... n the general human population
@ast
Pre-existing immunity against ...... n the general human population
@en
Pre-existing immunity against ...... n the general human population
@nl
prefLabel
Pre-existing immunity against ...... n the general human population
@ast
Pre-existing immunity against ...... n the general human population
@en
Pre-existing immunity against ...... n the general human population
@nl
P2093
P2860
P50
P356
P1476
Pre-existing immunity against ...... n the general human population
@en
P2093
Carla Oseroff
Jason A Greenbaum
Kerrie Vaughan
Maya F Kotturi
Nima Salimi
Randi Vita
P2860
P304
P356
10.1073/PNAS.0911580106
P407
P577
2009-12-01T00:00:00Z